Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA‐Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device-Reference-Cited by-同舟云学术

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA‐Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device

Published:2019-03-12 Issue:8 Volume:59 Page:1078-1084
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Krieter Philip A.¹,Chiang C. Nora¹,Gyaw Shwe¹,McCann David J.¹

Affiliation:

1. National Institute on Drug AbuseNational Institutes of Health Bethesda MD USA

Funder

NIH Office of the Director

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1401

Reference17 articles.

1. National Institute on Drug Abuse.Overdose death rates revised 2018.https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed October 17 2018.

2. A study of some of the pharmacologic actions of fentanyl citrate

3. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review

4. A response to the opioid overdose epidemic: naloxone nasal spray

5. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery;International Journal of Pharmaceutics;2024-07

2. Intranasal Delivery of Medications for the Treatment of Neurologic Conditions: A Pharmacology Update;Journal of Neuroscience Nursing;2024-06-11

3. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone;Clinical Pharmacokinetics;2024-03-14

4. Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone;The Journal of Clinical Pharmacology;2024-03-04

5. Updated Estimates of Annual U.S. Health System Spending from a Hypothetical National Naloxone Co-Prescribing Mandate;Substance Use & Misuse;2023-08-23